Company / SG&A per Share
AXIM BIOTECHNOLOGIES, INC. SG&A per Share History
FY2015-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.01
FY2023
5-year range
$0.01 / $0.09
FY2019-FY2023
Trend
-60.7%
vs FY2022
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $0.06 to $0.01 over the past 5 years.
Based on SEC 10-K filings.
0.01 in FY2023 with a 5-year CAGR of -27.5%.
Improved from $0.06 to $0.01 over the past 5 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -27.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2023, sg&a per share decreased 60.7% year-over-year.
- Peak sg&a per share was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -18.18 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2023 | $0.01 | -60.7% |
| FY2022 | $0.03 | -49.0% |
| FY2018 | $0.06 | +69.4% |
| FY2017 | $0.03 | -60.3% |
| FY2016 | $0.09 | -70.0% |
| FY2015 | $0.29 | - |
| FY2013 | - | - |
| FY2012 | - | - |
| FY2011 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 29, 2026